Luveniq voclosporin regulatory update

Lux submitted an NDA to FDA and an MAA to European Medicines Agency (EMA) for Luveniq voclosporin (LX211) to treat non-infectious uveitis in the intermediate or posterior segments of the eye. Lux requ...